Houston, TX, United States of America

Junghae Suh

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: William Marsh Rice University. Active years: 2018-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junghae Suh. Retrieved from https://idiyas.com/inventor/junghae-suh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Junghae Suh: Innovator in Adeno-Associated Virus Technology

Introduction

Junghae Suh is a prominent inventor based in Houston, Texas. He has made significant contributions to the field of virology, particularly in the development of adeno-associated viruses (AAV). His innovative work has led to the filing of multiple patents that enhance the properties and applications of these viral vectors.

Latest Patents

Junghae Suh holds two notable patents. The first patent focuses on the "Modification of n-terminal region of capsid proteins for enhanced properties of adeno-associated viruses." This invention provides viral compositions and methods for modulating AAV properties, including transduction efficiency, virus capsid assembly, viral genome packaging, capsid stability, and intracellular processing. The engineered AAVs with modifications in the N-terminal region of the capsid proteins VP1 or VP2 exhibit varying effects on viral properties, particularly transduction efficiency. Corresponding nucleic acids and amino acids are also provided in this patent.

The second patent is titled "Encryption of adeno-associated viruses with enzymatically decoded peptide locks." This invention introduces a peptide lock that comprises at least one peptide genetically encoded into the AAV capsid. This lock blocks biologically active domains on the virus capsid surface. The peptide lock can be processed by biological enzymes to restore the biological behavior of the capsid-displayed domains, effectively 'decoding the lock.' The method involves providing at least one peptide, an AAV capsid, and genetically inserting the peptide into the capsid to block the biologically active domains.

Career Highlights

Junghae Suh is affiliated with William Marsh Rice University, where he conducts his research and development in virology. His work has garnered attention for its potential applications in gene therapy and other medical fields.

Collaborations

He collaborates with notable colleagues, including Justin Judd and Jonathan Silberg, who contribute to his research endeavors.

Conclusion

Junghae Suh's innovative work in the field of adeno-associated viruses has led to significant advancements in viral technology. His patents reflect a commitment to enhancing the capabilities of AAVs for various applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…